Legal Representation
Attorney
MARY A FRANCIS
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 12, 2000 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 7, 1999 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 15, 1999 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 14, 1999 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 26, 1999 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 16, 1999 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Dec 1, 1998 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Nov 20, 1998 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceuticals in the nature of coagulation antagonists for the treatment and prevention of myocardial infarction, stroke, atherosclerosis, angina, and conditions of the cardiovascular and circulatory systems
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a highly stylized representation of a structural drawing of a chemical receptor site.
Classification
International Classes
005